{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0008785/OMIM:205950","label":"Anemia, sideroblastic, 2, pyridoxine-refractory","mondoId":"MONDO:0008785","onsetQualifier":null,"recordKeys":["249212b98bcd2e3f66337c428eb8af5a5c6b60ce98aa3ed0c8c182f2e2d11723","40d1e5ab02cbbfacb9cd8772b50d7024341050eab6ae44c10eb599625185379f","4ddf1feb52224dacf92db271ee70e6bde75f899b021e1efdbee74d2396460e8d","691b8e37daf30ea68b866ecd7b4253d87238ce27e7e5d4174142cb547f097218","bea58bb7ad3a13c320df2e954757a5e8873a6d143ba0b77e2ea7244c2dc26385","f9f0e8fad6f81a5ac9438f2272f1641a1ce9a8047e9f3f2540f3df812c3ec029"],"recordQualifiers":{},"scopeLabel":"OMIM:205950","sourceIds":["OMIM:205950"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0008785/OMIM:205950"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":3,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":6,"sourceGroups":{"omim":1,"orphanet":0,"published":5}},"features":[{"hpoId":"HP:0001903","label":"Anemia","primary":false},{"hpoId":"HP:0025066","label":"Decreased mean corpuscular volume","primary":false},{"hpoId":"HP:0012463","label":"Elevated transferrin saturation","primary":false},{"hpoId":"HP:0032231","label":"Hypochromia","primary":false},{"hpoId":"HP:0003281","label":"Increased circulating ferritin concentration","primary":false},{"hpoId":"HP:0001924","label":"Sideroblastic anemia","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0016828","records":[{"frequencyKind":"reported","key":"249212b98bcd2e3f66337c428eb8af5a5c6b60ce98aa3ed0c8c182f2e2d11723","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:205950","disease_name":"Anemia, sideroblastic, 2, pyridoxine-refractory","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0032231","is_excluded":false,"label":"Hypochromia","onset_id":null,"reference":"OMIM:205950","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"40d1e5ab02cbbfacb9cd8772b50d7024341050eab6ae44c10eb599625185379f","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:205950","disease_name":"Anemia, sideroblastic, 2, pyridoxine-refractory","evidence":"PCS","frequency_raw":"11/18","hpo_id":"HP:0025066","is_excluded":false,"label":"Decreased mean corpuscular volume","onset_id":null,"reference":"PMID:19412178","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4ddf1feb52224dacf92db271ee70e6bde75f899b021e1efdbee74d2396460e8d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:205950","disease_name":"Anemia, sideroblastic, 2, pyridoxine-refractory","evidence":"PCS","frequency_raw":"9/9","hpo_id":"HP:0012463","is_excluded":false,"label":"Elevated transferrin saturation","onset_id":null,"reference":"PMID:19412178","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"691b8e37daf30ea68b866ecd7b4253d87238ce27e7e5d4174142cb547f097218","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:205950","disease_name":"Anemia, sideroblastic, 2, pyridoxine-refractory","evidence":"PCS","frequency_raw":"14/14","hpo_id":"HP:0003281","is_excluded":false,"label":"Increased circulating ferritin concentration","onset_id":null,"reference":"PMID:19412178","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"bea58bb7ad3a13c320df2e954757a5e8873a6d143ba0b77e2ea7244c2dc26385","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:205950","disease_name":"Anemia, sideroblastic, 2, pyridoxine-refractory","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001924","is_excluded":false,"label":"Sideroblastic anemia","onset_id":null,"reference":"PMID:19412178","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"f9f0e8fad6f81a5ac9438f2272f1641a1ce9a8047e9f3f2540f3df812c3ec029","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:205950","disease_name":"Anemia, sideroblastic, 2, pyridoxine-refractory","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"PMID:19412178","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"autosomal-recessive-sideroblastic-anemia","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"autosomal recessive sideroblastic anemia"},"schemaVersion":1}